SEC vs. Tilray: What regulators wanted to know about the largest U.S. pot IPO

Cannabis producer and distributor Tilray Inc. removed the entirety of the letter from Chief Executive Brendan Kennedy after Securities and Exchange Commission raised questions about how well it balanced the company’s goals with the associated risks, according to documents made public this week.